sept9 dna Search Results


epi procolon (methylated sept9 dna)  (Deibel Laboratories)
90
Deibel Laboratories epi procolon (methylated sept9 dna)
Overview of study characteristics, clinical applications, evaluated strategies, and overall judgement
Epi Procolon (Methylated Sept9 Dna), supplied by Deibel Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/epi procolon (methylated sept9 dna)/product/Deibel Laboratories
Average 90 stars, based on 1 article reviews
epi procolon (methylated sept9 dna) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
sept9 dna methylation assay  (Quest Diagnostics)
90
Quest Diagnostics sept9 dna methylation assay
Overview of study characteristics, clinical applications, evaluated strategies, and overall judgement
Sept9 Dna Methylation Assay, supplied by Quest Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sept9 dna methylation assay/product/Quest Diagnostics
Average 90 stars, based on 1 article reviews
sept9 dna methylation assay - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
plasma sept9 dna methylation test epi procolon  (MultiTarget Pharmaceuticals)
90
MultiTarget Pharmaceuticals plasma sept9 dna methylation test epi procolon
Overview of study characteristics, clinical applications, evaluated strategies, and overall judgement
Plasma Sept9 Dna Methylation Test Epi Procolon, supplied by MultiTarget Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/plasma sept9 dna methylation test epi procolon/product/MultiTarget Pharmaceuticals
Average 90 stars, based on 1 article reviews
plasma sept9 dna methylation test epi procolon - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Overview of study characteristics, clinical applications, evaluated strategies, and overall judgement

Journal: Pharmacoeconomics

Article Title: Health Economic Evidence and Modeling Challenges for Liquid Biopsy Assays in Cancer Management: A Systematic Literature Review

doi: 10.1007/s40273-023-01292-5

Figure Lengend Snippet: Overview of study characteristics, clinical applications, evaluated strategies, and overall judgement

Article Snippet: 10 , Deibel et al. (2021) [ ] , CEA/CUA (USA) , Screening and early detection General population from birth until either mortality or reaching the upper age limit of 100 years , Methylated SEPT9 DNA , Epi proColon (methylated SEPT9 DNA) Other strategies (no screening, colonoscopy, FIT, ColoGuard, and PolypDx) , Cost-effective Epi proColon was cost-effective compared with no screening, with a 100% adherence scenario; Epi proColon was cost-effective compared with no screening, colonoscopy, or FIT (2 years), with real-world adherence scenario; Epi proColon was dominated compared with ColoGuard in both scenarios..

Techniques: Biomarker Discovery, Selection, Clinical Proteomics, Mutagenesis, Methylation, Adjuvant, Marker, Imaging, Spectroscopy